Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat
(NASDAQ: TNGX) Delayed: 30.81 +0.99 (3.32%)
Previous Close $29.82    52 Week High $ 
Open $29.55    52 Week Low $ 
Day High $30.90    P/E N/A 
Day Low $29.48    EPS $ 
Volume 7,186,980